Biotechnology

Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Oct 09, 2024, 16:50 ET AMERICAS GOLD AND SILVER CORPORATION ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT OF SUBSCRIPTION RECEIPTS TO C$45 MILLION

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR TO A U.S. PERSON./ TORONTO, Oct. 9, 2024 /CNW/ -...

Oct 09, 2024, 16:01 ET Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

Oct 09, 2024, 09:00 ET Groundbreaking innovators to revolutionize arthritis care through Arthritis Society Canada and Creative Destruction Lab partnership

Four arthritis-focused companies will receive support to launch their innovations into market, improving the future for people living with arthritis...

Oct 09, 2024, 08:16 ET BIOTECanada Welcomes Three New Members to its Board of Directors

OTTAWA, ON, Oct. 9, 2024 /CNW/ - BIOTECanada, the national industry association representing the biotechnology ecosystem in Canada, is pleased to...

Oct 09, 2024, 07:11 ET AMERICAS GOLD AND SILVER TO CONSOLIDATE THE GALENA COMPLEX IN TRANSACTION WITH ERIC SPROTT; PAUL ANDRE HUET TO BE APPOINTED CHAIRMAN AND CHIEF EXECUTIVE OFFICER

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR TO A U.S. PERSON./ TORONTO, Oct. 9, 2024 /CNW/ -...

Oct 08, 2024, 09:00 ET Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today the finalization of a...

Oct 08, 2024, 07:00 ET BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan,...

Oct 07, 2024, 14:41 ET The U.S. Fish and Wildlife Service Rejects Petition to List Long-Tailed Macaques Under the Endangered Species Act

On October 7, 2024, the U.S. Fish and Wildlife Service ("USFWS" or "the Service") declined to accept a petition filed by People for the Ethical...

Oct 07, 2024, 12:00 ET GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials

GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), and Allterum Therapeutics, a Fannin-Founded Company, are...

Oct 04, 2024, 21:24 ET BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed the fifth tranche (the...

Oct 04, 2024, 09:00 ET FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket

USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among...

Oct 04, 2024, 07:00 ET Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, is issuing a...

Oct 03, 2024, 18:00 ET DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)

– Transaction adds another innovative rare disease therapy to the DHT portfolio – – Novel deal structure offers predictable annual cash flows as well ...

Oct 03, 2024, 10:15 ET IBC launches RadSep, Inc.: Best-in-class, highly selective separations using Molecular Recognition Technology™ (MRT™) for production of critical radioisotopes essential to cancer therapies

IBC Advanced Technologies Inc. (IBC) announces the launch of its subsidiary, RadSep Inc. (RadSep), dedicated to best-in-class, highly selective...

Oct 03, 2024, 07:00 ET Ninth Circuit Decision Marks Critical Legal Victory for U.S. FDA in Mission to Protect Patients from Unregulated Cell Therapy Products

VANCOUVER, BC, Oct. 3, 2024 /CNW/ - The International Society for Cell & Gene Therapy (ISCT) celebrates a major legal victory in the ongoing fight to ...

Oct 01, 2024, 09:00 ET Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment

MONTREAL, Oct. 1, 2024 /CNW/ - Thryv Therapeutics, a clinical stage biotech company dedicated to developing treatments for rare and life-threatening...

Oct 01, 2024, 07:14 ET Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Tagworks Pharmaceuticals BV ("Tagworks"), a precision oncology company using its proprietary Click-to-Release treatment platform to develop a new...

Sep 30, 2024, 10:35 ET Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE:...

Sep 30, 2024, 06:59 ET Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment

Viatris, a global healthcare company, today announced the launch of PrViagra® ODF (sildenafil citrate orodispersible film) in Canada – a new form of...

Sep 26, 2024, 09:00 ET Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis

TORONTO, Sept. 26, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has accepted for review its New ...

Sep 26, 2024, 08:00 ET AbbVie and SpinUp Foster Canadian Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award

National competition, in collaboration with SpinUp, the University of Toronto's lab-based life sciences accelerator, demonstrates AbbVie's commitment ...

Sep 25, 2024, 15:50 ET Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

– First regulatory authorization of a CRISPR-based gene-editing therapy in Canada – TORONTO, Sept. 25, 2024 /CNW/ - Vertex Pharmaceuticals...

Sep 25, 2024, 01:05 ET Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced new dermatology data presented at the...

Sep 24, 2024, 18:01 ET EADV Congress 2024: Semaglutide improves outcomes for obese patients with common skin condition, new study shows

This is the first study to explore the use of semaglutide for HS, marking a critical milestone in the search for effective treatments for this...

Sep 24, 2024, 11:45 ET Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine

Omicron KP.2 variant adapted vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE